Amsterdam-based, female-led private equity firm Karmijn Kapitaal has closed its second fund on €90m, tripling its funds under management.
Fund has a target of $600m, which it plans to reach by next year, according to Kommersant
Existing investors including Institut Català de Finances also take part in the financing
Biotech company initially raised €12m in December 2018
Amount includes the capital raised by Eurazeo Growth III, which has now collected more than €500m